Chromosomal abnormalities and autism  by El-Baz, Farida et al.
The Egyptian Journal of Medical Human Genetics (2016) 17, 57–62HO ST E D  BY
Ain Shams University
The Egyptian Journal of Medical Human Genetics
www.ejmhg.eg.net
www.sciencedirect.comORIGINAL ARTICLEChromosomal abnormalities and autism* Corresponding author. Reham M Elhossiny, lecturer of Pediatrics,
Faculty of Medicine, Ain Shams, Cairo, Egypt. Tel.: +201001506555.
Peer review under responsibility of Ain Shams University.
http://dx.doi.org/10.1016/j.ejmhg.2015.05.002
1110-8630  2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Farida El-Baz a, Mohamed Saad Zaghloul a, Ezzat El Sobky a,
Reham M Elhossiny a,*, Heba Salah a, Neveen Ezy Abdelaziz ba Pediatric Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
b Children with Special Needs Unit – Armed Rheumatology and Rehabilitation Center (ARRC), EgyptReceived 19 April 2015; accepted 11 May 2015
Available online 19 June 2015KEYWORDS
Autism;
Chromosomal abnormality;
High resolution karyotypeAbstract Background: Autism is a neurodevelopmental disorder characterized by clinical, etio-
logic and genetic heterogeneity. Many surveys revealed cytogenetically visible chromosomal abnor-
malities in 7.4% of autistic patients documented as well as several submicroscopic variants. This
study had been conducted to identify some aspects that might be involved in the pathogenesis of
autism which is necessary for offering proper genetic counseling to families of autistic patients
and their role in the prenatal diagnosis of autism.
Methods: This cross sectional study was conducted at the Child Psychiatry Clinic, Pediatric
Hospital, Ain Shams University on 30 autistic patients who were subjected to the following tools:
Conﬁrmation of diagnosis using DSM-IV-TR criteria, IQ assessment using Stanford-Binet intelli-
gence scale and assessment of severity of autistic symptoms using childhood autism rating scale
(CARS). Full clinical examination, neurological examination, EEG, audiological assessment were
also done. High resolution karyotyping was done for detection of numerical or structural chromo-
somal abnormalities as deletion, duplication, translocation of chromosomes.
Results: All the results of cytogenetic analysis were normal with no detectable numerical or
structural chromosomal abnormalities. Males are affected more than females, only one case had
history of drug intake (progestin), two cases had history of anti-D injection and two cases had his-
tory of diabetes mellitus during pregnancy. Four cases had history of respiratory distress and seven
cases had history of jaundice. Two cases had history of generalized tonic clonic convulsion and four
cases had history of EEG abnormalities. Fifteen cases of our autistic patients had mild mental retar-
dation and six cases had moderate mental retardation.
Conclusion: Chromosomal abnormalities were not detected in the studied autistic children, and
so the relation between the genetics and autism still needs further work up with different study
methods and techniques.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Autism is a syndrome characterized by impairment in social
communication, repetitive behavior, abnormal movement
58 F. El-Baz et al.and sensory dysfunction [1]. It is currently estimated that 3–6
children out of every 1000 worldwide have autism with three
to four fold higher incidence in males than in females [2].
Autism is a neuro-developmental disorder characterized by
clinical, etiologic and genetic heterogeneity, it is often associ-
ated with other conditions such as disorders of the CNS
(tuberous sclerosis), developmental delay, attention deﬁcit, epi-
lepsy, anxiety and mood disorders [3]. Many surveys revealed
cytogenetically visible chromosomal anomalies in 7.4% of
autistic patients, among the most consistent cytogenetic ﬁnd-
ings are fragile-x and duplication of maternal chromosome
15q11–13 [4].
Environmental component is another important aspect of
research in autism. Environmental factors such as mercury
and radiation have been proposed as possible causes of autism
[5]. Several studies provided strong evidence against the
hypotheses that MMR vaccination causes autism [6]. The
causes of autism are still unclear, although results from
twin and family studies provide evidence for strong genetic
contribution, with the probability of multiple genetic loci
involved [7].
Despite signiﬁcant research on prenatal, natal, neonatal
and other risk factors in autism, the causal nature of these
associations is still disputed due to several current method-
ological limitations of studies [8].
2. Patients and methods
The present study enrolled 30 cases with autism diagnosed
with DSM-IV-TR criteria [9,10]. The patients were 23 males
(76.7%) and 7 females (23.3%). Their age ranged from 2 to
9 years. They were recruited from the psychiatric clinic, pedi-
atric hospital, Ain Shams University.
All cases were subjected to the following:
1. Detailed history taking with special emphasis on, onset,
course, age, sex and consanguinity of the patients.
 Antenatal history included history of threatened abor-
tion, chronic illness as diabetes mellitus and hypertension,
medications as antiepileptics, antithyroid, and progestin,
and anti-D injection.Figure 1 Degree of autism according to CARS in autistic
patients. Natal and postnatal history including, gestational age,
complications during delivery, history of prematurity,
perinatal problems and postnatal course especially occur-
rence of neonatal hypoxia, respiratory distress and
jaundice.
 Developmental assessment included both motor and
mental development: age of sitting without support,
walking unassisted, ﬁrst spoken word, combining words,
accurate details of cognitive abilities, gross and ﬁne
motor functions and history of vaccination.
 Past history including: major childhood illnesses, history
of allergy and gastrointestinal disorders as diarrhea or
constipation.
 Family history for any similar condition, any genetic dis-
ease or other psychological or mental disorders in the
family.
2. Through clinical examination
 Laying stress on neurological examination.
3. Psychiatric evaluation:
 Conﬁrmation of diagnosis using DSM-IV-TR criteria of
autism i.e., impairment in language, social skills and
restricted stereotyped interests or activity.
 Assessment of intelligence quotient (IQ) using Stanford-
Binet intelligence scale (1986) [11], which is used to mea-
sure the cognitive abilities of children aging from 2 to
16 years. Abnormal intellectual function is diagnosed
when IQ is below 70.
 Assessment of severity of autistic symptoms using child-
hood autism rating scale (CARS) [12], which rates the child
from one to four in each of ﬁfteen areas (relating to people,
emotional response, imitation, body use, object use, listen-
ing response, fear or nervousness, verbal and non verbal
communication, activity level, consistency of intellectual
response, adaptation to change, visual response, taste,
smell, touch response and general impression).
4. Genetic evaluation:
 Pedigree of family of autistic patients.
 Cytogenetic analysis by high resolution banding tech-
niques [13] which have facilitated the identiﬁcation of chro-
mosomes and major structural abnormalities by
examining chromosomes with more number of bands by
obtaining prophase and prometaphase chromosomes
which are less condensed. High resolution banding facili-
tates better karyotyping analysis andmore precise designa-
tion of breakpoints and subtle chromosome abnormalities
[13]. Prophase and prometaphase cells can be obtained by
harvesting the cultures without metaphase block, or by
reducing the concentration of the blocking agent (col-
cemid) and the duration of treatment. An alternative
approach is to accumulate the maximum number of cells
at a particular stage of the mitotic cell cycle and release
them synchronously to capture the early stages of mitosis,
prophase and prometaphase. This approach with a brief
exposure to low concentration of colcemid, is employed
to obtain considerably long chromosomes.
3. Results
The present study included 30 cases with autism diagnosed
with DSM-IV-TR criteria [9,10]. The patients were 23 males
Table 2 Speciﬁc symptoms of autism.
Number Percent
Delayed speech 17 56.7
Lack of eye contact 9 30.0
Stereotyped movement 1 3.3
Mixed (lack of eye contact and stereotyped
movement)
3 10.0
Total 30 100.0
Table 3 Antenatal, natal and postnatal history in autistic
patients.
Number Percent
Antenatal history
ve 23 76.7
Drug intake (progestin) 1 3.3
Anti-D injection during pregnancy 2 6.7
Chronic illness (DM) 2 6.7
Fetal loss 2 6.7
Natal history
NVD 14 46.7
CS 16 53.3
Postnatal history
ve 14 46.7
Res. distress 4 13.3
Jaundice 7 23.3
Resuscitation required 1 3.3
ICU admission 1 3.3
Mixed 3 10.0
ve = negative; DM= diabetes mellitus; NVD= normal vaginal
delivery; CS = cesarean section; ICU= intensive care unit.
Table 4 The level of IQ and degree of autism according to
CARS in autistic patients.
Number Percent
Level of IQ
Moderate MR 6 20.0
Mild MR 15 50.0
Below average 8 26.7
Normal IQ 1 3.3
Total 30 100.0
Degree of autism (CARS)
Mild 10 33.3
Moderate 9 30
Severe 11 36.7
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9 years, with a mean age of 4.79 ± 1.9 SD. 16 patients
(53.3%) of our autistic patients were diagnosed at age
<2 years old and 14 patients (46.7%) were diagnosed with
autism >2 years old (Table 1).
The ﬁrst symptom of autism in our patients was delayed
speech in 56.7%, followed by lack of eye contact in 30%,
stereotyped movements in 3%, while mixed presentation was
found in 10% (Table 2).
There was no history of prenatal complications in 76.7% of
mothers of autistic children, but 3.3% had history of drug
intake as progestin, 6.7% had history of anti-D injection,
6.7% had history of diabetes mellitus during pregnancy and
6.7% had history of fetal loss. 53.3% of autistic patients were
delivered by cesarean section and 46.7% were delivered by
normal vaginal delivery.
In our study 23.3% had jaundice, 13.3% had respiratory
distress and 3.3% needed cardiopulmonary resuscitation after
birth (Table 3). Fifty percent of our patients had mild mental
retardation (IQ = 50–70%), 26.7% had below average men-
tality (IQ = 71–89) and 80% with moderate mental retarda-
tion (IQ = 31–49). Eleven cases of our autistic patients were
severely autistic (36.7%), ten cases had history of mild degree
of autism (33.3%) and nine cases were with moderate degree of
autism (30%) (Table 4) (Fig. 1). 6.7% of our autistic patients
had attacks of generalized tonic colonic convulsions and
93.3% were normal (Table 5).
Seventy-six percent of autistic patients were males with nor-
mal results of high resolution karyotyping and 23% were
females with normal results of high resolution karyotyping
(Figs. 2–4).
4. Discussion
This study was conducted on 30 autistic children, 53.3% of
autistic children were diagnosed before the age of 2 years,
while the remaining 46.6% were diagnosed after the age of
2 years. Autistic group’s age ranged from 2 to 9 years with
an average age of 5.68 years. These ﬁndings are against
Jonson [14], who found that 75% of autistic children were
diagnosed <3 years and the remaining 25% were diagnosed
>3 years old. In the current study 76.7% of autistic children
were males and 23.3% were females. This goes with other stud-
ies, one of them involved 2685 patients with autism, and the
prevalence was more in males than females [15].
The goal of this study was to identify the role of chromoso-
mal abnormalities in the etiology of autism and detect whether
cytogenetic analysis including high resolution banding tech-
nique is useful to identify autistic children or not. Several
investigations on autistic children have previously reported aTable 1 Patients’ age, age of diagnosis and sex of autistic
patients.
Age 2–9 years (4.7 ± 1.9)
Age of diagnosis
<2 years 16 53.3%
>2 years 14 46.7%
Sex
Male 23 76.7%
Female 7 23.3%
Total 30 100.0
MR=mental retardation; IQ = intelligent quotient;
CARS= childhood autism rating scale.remarkable variety of chromosomal aberrations which
involved all the chromosomes [16].
In our study chromosomal abnormalities were negative.
This result may be due to small number of the patients studied
and low incidence of chromosomal abnormalities in autistic
patients and so more advanced techniques as microarray and
Table 5 Convulsion in autistic patients.
Number Percent (%)
Convulsion
ve 28 93.3
+ve 2 6.7
Total 30 100.0
+ve = positive; ve = negative.
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These results go with the results of Selvi et al. [17] study which
showed that no complex rearrangement or chromosomal
abnormalities were detected as they performed high resolution
karyotyping on 12 autistic patients, peripheral blood samples
were taken, cultured and processed after which 25 metaphases
from each sample were analyzed in 100 magniﬁcation to rule
out the chromosomal abnormalities.
Zhong et al. [18] were against our results as they found that
there are chromosomal abnormalities detected in four out of
ﬁfty cases and about 8% by high resolution banding which
are conﬁrmed by FISH. These changes were one case with
translocation between chromosome 4 and 6 t (4,6) (q23–
24,p21), one case with longer short arm of chromosome
21(21p+) and two cases with pericenteric inversion of chro-
mosome 9.
The prevalence of chromosomal abnormalities was low in
several studies including Tajeran et al. [19] who found that
among ﬁfty clinically autistic children, only one patient a
7 year old boy was with a ring chromosome 14 (4%). The
karyotype of the patient was 46,xy,r (14). Chromosomal alter-
ations which were observable by microscope have been
reported in 3–5% of ASD cases [20]. The most frequent abnor-
malities are 15q11–13 duplications, 2q37 and 22q11 and
22q11.3 deletions [21].
Clinical genetic approach was done to identify genetic
causes of autism and found positive genetic ﬁndings in about
5% with high resolution chromosomal abnormality, 5% with
fragile x syndrome, 5% with Rett syndrome, 10% with other
genetic syndromes (tuberous sclerosis) and 10% with struc-
tural genomic deletions or duplications using chromosomal
microarray [22].Figure 2 High resolution karyotyping in autistic children.Shen et al. [23] performed a study on 993 patients with aut-
ism. They used high resolution karyotyping, fragile x testing
and chromosomal microarray. They found abnormal kary-
otyping in 2.2%, abnormal fragile x testing in 0.5% and
microdeletions and microduplications in 18.2% using chromo-
somal microarray.
Rare microscopic chromosomal abnormalities occur at a
rate of 7.4% in autism. Moreover, multiple studies have con-
verged on particular chromosomal abnormalities in autism,
the most common abnormalities are maternally inherited
duplications at 15q11–13. These duplications are found in
1–3% of patients diagnosed with idiopathic autism [24].
Several studies have originated from or been strongly sup-
ported by traditional cytogenetic evidence leading to a number
of ﬁndings. For example, Thomas et al. [25] reported de novo
deletions or translocations that affect the same region on X
chromosome at Xp22.3 in three girls with autism.
This study revealed no signiﬁcant contribution of chromo-
somal abnormalities to the etiology of autism. So it appears
that to date, only a small percentage of autistic disorders have
been associated with speciﬁc chromosomal abnormalities [26].
As a result there is no conclusive factor that can be elicited
as being a risk for autism.
Chromosomal abnormality involvement in the pathogene-
sis of autism is not new, so many investigators focused on
genetic pathogenesis of this neurodevelopmental disorder
using different techniques such as array CGH and cytogenetic
analysis [27]. Chromosomal rearrangement plays an important
role in the etiology of autism, hence chromosomal abnormali-
ties have provided considerable insight into the candidate gene
and possible molecular pathway involved in autism [28].
Autism is not a single clinical disorder. The variable phenotype
spectrum might be suspected as a polygenic and multifactorialFigure 3 Karyotype – normal male high resolution karyotyping
in a case of our autistic patients.
Figure 4 Karyotype – normal female high resolution karyotyp-
ing in a case of our autistic patients.
Chromosomal abnormalities and autism 61disorder, however many questions about autism remain poorly
explained [29].
In our study 56.7% of our patients had delayed speech, and
these results are in accordance with Zwavigendum et al. [30],
who found that children with autism developed several speciﬁc
behavioral markers including, lack of eye contact, loss of social
smile, loss of social interest and delay in expressive and recep-
tive language.
Dalton et al. [31] hypothesize that, the maternal antibodies
immunoglobulin G (IgG) in the mothers’ blood cross the pla-
centa and enter into the fetus brain, react against fetal brain
proteins and cause autism. In our study 6.7% of mothers of
autistic children received anti-D injection as they were rhesus
negative.
Bolten et al. [32] suggested additional differentiation
between complications based on the severity as determined
by the selection of obstetric complication known to be associ-
ated with autism.
More than half of the cases at about 53.3% were delivered
by cesarean section, yet it seemed to have no impact on the eti-
ology of autism. Other studies thought that cesarean section is
a risk factor for autism [33]. Kolevzon and Reichenberg [34]
disapproved that cesarean section can be accused as a risk fac-
tor for autism.
Only one case of mothers of autistic children received pro-
gestins during pregnancy, consistent with Lidisky and
Schneider [35] who reported that there was no drug intake cor-
relation to the autistic disorder as well.
Postnatal factors like hyper-bilirubinemia are also alarming
and suspected in the etiology of autism. In the current study
there was no signiﬁcant correlation between neonatal jaundice
and autism, supporting the belief of many researchers as
Gardener et al. [36]. On the other hand, few suggested thathyperbilirubinemia occurs more frequently than expected
among children later diagnosed with autism [37].
Hara [38] found that seizures that occur in autistic children
are most commonly of the generalized type and said that epi-
lepsy is one of the negative factors of cognitive, adaptive and
behavioral outcomes for individuals with autism. In our study
6.7% of our autistic patients have generalized attacks of
convulsion.
Kaplan et al. [39] stated that, mental retardation usually
coexists with autistic disorder. About 40% of autistic children
are moderately or severely retarded. In our study about 50%
have mild mental and 20% were with moderate mental
retardation.
5. Conclusion
Chromosomal abnormalities were not detected in the studied
autistic children, and so the relation between chromosomal
abnormalities and autism still needs further work up with dif-
ferent study methods and techniques.
But, no matter how rare the cause is or whether it is genetic
or environmental, these factors have the potential to provide
clues to the etiology and neurobiology of autism.
What is known about environmental agents does not
account for many cases, but it is a source of information on
the nature of autism.
6. Recommendations
Future studies using a larger case group with stress on the role
of genetic susceptibility and the role of family studies to deter-
mine the susceptible genes are necessary. Advanced techniques
should be used for detection of the genetic cause of autism as
microarray.
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